CAS No. |
20977-05-3 |
中文名称 |
[(2S,3S,4S,5R,6R)-6-(((3S,5R,6aS,9S)-4a-(((3-乙酰氧基-2-甲基丁酰基)氧基)甲基)-4-羟基-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-二十氢-3,5-环氧picen-10-基)氧基)-4-羟基-3-(((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-5-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-羧酸]钠盐 |
英文名称 |
(2S,3S,4S,5R,6R)-6-(((3S,5R,6aS,9S)-4a-(((3-acetoxy-2-methylbutanoyl)oxy)methyl)-4-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-3,5-epoxypicen-10-yl)oxy)-4-hydroxy-3-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid, sodium salt |
别名 |
PD087204 | Escin monosodium salt | Aescusan sodium salt | Escin, sodium salt | Escin, monosodium salt | Na-Aescinat | Sodium-Aescinate | D85121 | Aescin sodium salt | A-4760 | AKOS026750634 | Sodium aescinate | EINECS 244-133-4 | Escin,monosodiumsalt |
标准英文名 |
(2S,3S,4S,5R,6R)-6-(((3S,5R,6aS,9S)-4a-(((3-acetoxy-2-methylbutanoyl)oxy)methyl)-4-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-3,5-epoxypicen-10-yl)oxy)-4-hydroxy-3-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid, sodium salt |
MDL No. |
MFCD01772116 |
分子式 |
C54H84NaO23+ |
分子量 |
1124.23
|
精确分子量 |
1123.53
|
SMILES |
CC(=O)OC(C)C(C)C(=O)OCC12C3CC(C)(C)[C@H](O[C@@H]1C[C@]1(C)C3=CCC3C4(C)CCC(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)[C@](C)(CO)C4CCC31C)C2O.[Na+] |
标准SMILES |
[Na+].CC1(C)CC2C3=CCC4C5(C)CCC(O[C@@H]6O[C@@H]([C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)[C@](C)(CO)C5CCC4(C)[C@]3(C)C[C@H]3O[C@@H]1C(O)C32COC(=O)C(C)C(C)OC(C)=O |
用途 |
Sodium aescinate is used for the treatment of cerebral edema, trauma- or surgery-induced swelling, and venous insufficiency disorders; it exhibits anti-inflammatory, anti-exudative, and venotonic effects, reduces capillary permeability, alleviates edema, enhances venous tone, improves microcirculation, and promotes lymphatic drainage; it also demonstrates hepatoprotective, anti-tumor, antioxidant, free radical scavenging, neuroprotective (particularly in ischemic brain injury), hypoglycemic, and gastroprotective activities (including inhibition of gastric acid secretion and promotion of gastrointestinal motility); clinically applied in acute facial neuritis, headache (including vascular, tension-type, and post-traumatic headaches), acute myelitis, cervical spondylosis with radiculopathy, lumbar disc herniation, hypertensive intracerebral hemorrhage, acute cerebral infarction, central serous chorioretinopathy, early postoperative inflammatory bowel obstruction, and pressure ulcers. |
InChIKey |
OJTQULAMLNBGOY-RRKCPRGASA-N |